A kind of method for enzymatic synthesis of (s)-2-aminobutanamide
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 江苏八巨药业有限公司
- Publication Date
- 2022-07-26
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to a method for synthesizing (S)-2-aminobutanamide by an enzymatic method, and belongs to the technical field of pharmaceutical intermediate synthesis. Background technique
[0002] Levetiracetam (LEV, trade name Kaipulan) is a piracetam drug developed by Belgian UCB company, chemical name is (S)-а-ethyl-2-oxo-1- Pyrrolidineacetamide. Compared with traditional drugs for treating epilepsy, LEV has a new mechanism of action and can be used as an additive to treat various epilepsy in children, especially for complex localized seizures and myoclonic seizures. Compared with similar drugs, LEV has the following advantages: (1) There is a large difference between the effective dose and the toxic dose, the drug is safe, and the side effects are small; (2) The main metabolic pathway does not pass through the liver drug enzyme system, and there is no interaction with other antiepileptic drugs. ; (3) Rapid oral absorption, absolute bioavai...